Longitude Capital Partners, LLC
CIK 0001430720 Name as filed on the most recent filing
Filed as Longitude Capital Partners, LLC (16)
55 transaction lines · from 16 filings · filed 2009-02-10 to 2017-12-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Collegium Pharmaceutical, Inc 2 filings
- ISSUER Corcept Therapeutics Inc 10 filings
- ISSUER Esperion Therapeutics, Inc. 4 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2017-12-08 |
Collegium Pharmaceutical, Inc COLL |
S, Open-market sale | 980,350 disposed | 17.34 | 16,999,269.00 | Form 4, filing 0001209191-17-065191 | |
| 2017-12-08 |
Collegium Pharmaceutical, Inc COLL |
S, Open-market sale | 19,650 disposed | 17.34 | 340,731.00 | Form 4, filing 0001209191-17-065191 | |
| 2016-11-25 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 14,451 disposed | 9.39 | 135,650.09 | Form 4, filing 0001209191-16-152057 | |
| 2016-11-25 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 290 disposed | 9.39 | 2,722.20 | Form 4, filing 0001209191-16-152057 | |
| 2016-11-23 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 12,352 disposed | 9.30 | 114,920.54 | Form 4, filing 0001209191-16-152057 | |
| 2016-11-23 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 248 disposed | 9.30 | 2,307.34 | Form 4, filing 0001209191-16-152057 | |
| 2016-11-22 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 9,411 disposed | 9.33 | 87,801.81 | Form 4, filing 0001209191-16-152057 | |
| 2016-11-22 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 189 disposed | 9.33 | 1,763.31 | Form 4, filing 0001209191-16-152057 | |
| 2016-11-21 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 116,058 disposed | 9.39 | 1,089,320.39 | Form 4, filing 0001209191-16-151526 | |
| 2016-11-21 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 2,327 disposed | 9.39 | 21,841.22 | Form 4, filing 0001209191-16-151526 | |
| 2016-11-18 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 98,586 disposed | 9.47 | 933,964.33 | Form 4, filing 0001209191-16-151526 | |
| 2016-11-18 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 1,976 disposed | 9.47 | 18,719.83 | Form 4, filing 0001209191-16-151526 | |
| 2016-11-17 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 318,764 disposed | 9.64 | 3,073,968.76 | Form 4, filing 0001209191-16-151526 | |
| 2016-11-17 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 6,389 disposed | 9.64 | 61,611.68 | Form 4, filing 0001209191-16-151526 | |
| 2016-11-16 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 17,052 disposed | 9.51 | 162,142.35 | Form 4, filing 0001209191-16-151019 | |
| 2016-11-16 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 342 disposed | 9.51 | 3,251.98 | Form 4, filing 0001209191-16-151019 | |
| 2016-11-15 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 154,359 disposed | 9.55 | 1,474,653.27 | Form 4, filing 0001209191-16-151019 | |
| 2016-11-15 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 3,094 disposed | 9.55 | 29,558.22 | Form 4, filing 0001209191-16-151019 | |
| 2015-05-12 |
Collegium Pharmaceutical, Inc COLL |
P, Open-market purchase | 196,070 acquired | 12.00 | 2,352,840.00 | Form 4, filing 0001209191-15-042801 | |
| 2015-05-12 |
Collegium Pharmaceutical, Inc COLL |
P, Open-market purchase | 3,930 acquired | 12.00 | 47,160.00 | Form 4, filing 0001209191-15-042801 | |
| 2015-03-24 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 554,348 disposed | 5.65 | 3,132,066.20 | Form 4, filing 0001144204-15-018083 | |
| 2015-03-20 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 300,447 disposed | 5.85 | 1,757,614.95 | Form 4, filing 0001144204-15-018083 | |
| 2015-03-20 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 230,333 disposed | 5.85 | 1,347,448.05 | Form 4, filing 0001144204-15-018083 | |
| 2015-03-20 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 4,617 disposed | 5.85 | 27,009.45 | Form 4, filing 0001144204-15-018083 | |
| 2014-11-18 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 4,592 disposed | 31.56 | 144,943.72 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-18 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 412 disposed | 32.14 | 13,240.73 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-18 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 92 disposed | 31.57 | 2,904.13 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-18 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 8 disposed | 32.13 | 257.05 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-17 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 200,591 disposed | 32.01 | 6,421,218.80 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-17 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 136,148 disposed | 32.93 | 4,483,884.62 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-17 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 135,816 disposed | 33.79 | 4,589,181.90 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-17 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 4,021 disposed | 32.01 | 128,718.24 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-17 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 2,728 disposed | 32.93 | 89,843.68 | Form 4, filing 0001144204-14-069746 | |
| 2014-11-17 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 2,722 disposed | 33.79 | 91,975.29 | Form 4, filing 0001144204-14-069746 | |
| 2014-10-09 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 924 disposed | 30.00 | 27,720.00 | Form 4, filing 0001144204-14-060795 | |
| 2014-10-09 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 19 disposed | 30.00 | 570.00 | Form 4, filing 0001144204-14-060795 | |
| 2014-10-07 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 11,692 disposed | 30.04 | 351,230.02 | Form 4, filing 0001144204-14-060376 | |
| 2014-10-07 |
Esperion Therapeutics, Inc. ESPR |
S, Open-market sale | 235 disposed | 30.04 | 7,059.47 | Form 4, filing 0001144204-14-060376 | |
| 2014-05-02 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 84,744 disposed | 4.07 | 345,060.62 | Form 4, filing 0001144204-14-027615 | |
| 2014-05-02 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 1,699 disposed | 4.07 | 6,917.99 | Form 4, filing 0001144204-14-027615 | |
| 2014-05-01 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 160,343 disposed | 4.12 | 661,334.70 | Form 4, filing 0001144204-14-027615 | |
| 2014-05-01 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 3,214 disposed | 4.12 | 13,256.14 | Form 4, filing 0001144204-14-027615 | |
| 2014-04-01 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 245,088 disposed | 4.28 | 1,049,540.34 | Form 4, filing 0001144204-14-020626 | |
| 2014-04-01 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 4,912 disposed | 4.28 | 21,034.66 | Form 4, filing 0001144204-14-020626 | |
| 2014-03-07 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 10,225 disposed | 4.00 | 40,900.00 | Form 4, filing 0001144204-14-014246 | |
| 2014-03-07 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 205 disposed | 4.00 | 820.00 | Form 4, filing 0001144204-14-014246 | |
| 2014-03-06 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 164,800 disposed | 4.00 | 659,315.36 | Form 4, filing 0001144204-14-014246 | |
| 2014-03-06 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 3,303 disposed | 4.00 | 13,214.31 | Form 4, filing 0001144204-14-014246 | |
| 2014-03-05 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 70,063 disposed | 4.01 | 280,938.62 | Form 4, filing 0001144204-14-014246 | |
| 2014-03-05 |
Corcept Therapeutics Inc CORT |
S, Open-market sale | 1,404 disposed | 4.01 | 5,629.76 | Form 4, filing 0001144204-14-014246 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Longitude Capital Partners, LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001430720
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6